Benzinga's M&A Chatter for Tuesday, October 18, 2016
The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday, October 18, 2016:
MakeMyTrip, ibibo Group to Consolidate Indian Travel Businesses
MakeMyTrip Limited (NASDAQ: MMYT) and ibibo Group have agreed to combine the two travel businesses in India, under MMYT. Prior to closing , the $180 million, 5-year convertible notes issued by MakeMyTripd to Ctrip.com (NASDAQ: CTRP) in January 2016 will be converted into common stock, giving Ctrip about 10% stake in the combined company.
The transaction is expected to close by the end of December 2016.
MakeMyTrip closed at $29.45 on Tuesday, up 44%.
Hearing Juniper LBO Chatter
Shares of Juniper Networks (NASDAQ: JNPR) rose to a high of $23.14 Tuesday, following a report that Carlyle Group (NASDAQ: CG) was working on a LBO of the netwrrking company. "Sources" said a deal could happen at $28 per share.
Carlyle Group declined comment on the rumor. A Juniper Networks spokesperson said the company does not comment on rumors or speculation.
Juniper Networks closed at $22.85 on Tuesday, up 1.87%.
Blackstone in Lead to Buy Team Health
Blackstone Group (NYSE: BX) is said be the favorite to acquire Team Health Holdings (NYSE: TMH), according to sources as reported by Reuters on Tuesday. The sources said Blackstone is negotiating the final terms for a deal.
Blackstone and Team Health declined to comment on the Reuters report.
Team Health closed Tuesday at $40.25, up 7.19%.
Unconfirmed LBO Chatter in Campbell Soup
Shares of Campbell Soup (NYSE: CPB) spiked to a high of $55.20 Tuesday, on unconfirmed market chatter that Coca-Cola (NYSE: KO) is working with 3G Captial to structure a take-over of Campbell. Sources say a potential deal could be value at approximately $66 per share or $20 Billion.
Last year a report surfaced that the Dorrance family, led by 17% shareholder Mary Alice Dorrance Malone, had hired an advisor to handle a potential sale of the company.
Campbell Soup closed Tuesday at $54.41, up 1.36%.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.